Laboratory tests remarkably found that the knockdown of CD44 reduces tumor cell adhesion to endothelial cells in vitro, and decreases overall tumor burden in the brain, lung, liver and skeleton as well as increased cell survival in vivo experiments [11]. The gene discussed is CD44; the disease is neoplasm.